Vivos Therapeutics (VVOS) Receivables - Net (2019 - 2026)
Vivos Therapeutics (VVOS) posted quarterly Receivables - Net of $1.8 million for Q1 2026, up 150.7% year-over-year from $718000.0 in Q1 2025, and up 12.5% quarter-over-quarter from $1.6 million in Q4 2025.
Vivos Therapeutics (VVOS) Receivables - Net (2019 - 2026) Analysis & Trends
Vivos Therapeutics (VVOS) has reported Receivables - Net for 8 consecutive years, with $1.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Receivables - Net rose 150.7% year-over-year to $1.8 million; the TTM figure through Mar 2026 stood at $1.8 million (up 150.7% YoY), while the FY2025 annual figure was $1.6 million, up 272.09% from the prior year.
- Receivables - Net climbed to $1.8 million in Q1 2026 per VVOS's latest filing, from $1.6 million in the prior quarter.
- Across five years, Receivables - Net topped out at $2.1 million in Q3 2025 and bottomed at $202000.0 in Q4 2023.
- Historically, Receivables - Net has averaged $816647.1 across 5 years, with a median of $525000.0 in 2024.
- Annual changes were most pronounced in 2022 — Receivables - Net sank 77.41% — and 2025, when it soared 370.04%.
- Vivos Therapeutics' Receivables - Net stood at $457000.0 in 2022, then plunged by 55.8% to $202000.0 in 2023, then soared by 112.87% to $430000.0 in 2024, then jumped by 272.09% to $1.6 million in 2025, then increased by 12.5% to $1.8 million in 2026.
- Business Quant data shows VVOS's Receivables - Net at $1.8 million in Q1 2026, $1.6 million in Q4 2025, and $2.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Vivos Therapeutics | 4.94 Mn | 3.14 Mn | 2.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.80 Mn |
| Mar 31, 2026 | 1.80 Mn |
| Dec 31, 2025 | 1.60 Mn |
| Dec 31, 2025 | 1.60 Mn |
| Sep 30, 2025 | 2.13 Mn |
| Sep 30, 2025 | 2.13 Mn |
| Jun 30, 2025 | 1.63 Mn |
| Jun 30, 2025 | 1.63 Mn |
| Mar 31, 2025 | 718,000.00 |
| Mar 31, 2025 | 718,000.00 |
| Dec 31, 2024 | 430,000.00 |
| Dec 31, 2024 | 430,000.00 |
| Sep 30, 2024 | 454,000.00 |
| Sep 30, 2024 | 454,000.00 |
| Jun 30, 2024 | 395,000.00 |
| Jun 30, 2024 | 395,000.00 |
| Mar 31, 2024 | 525,000.00 |
| Mar 31, 2024 | 525,000.00 |
| Dec 31, 2023 | 202,000.00 |
| Dec 31, 2023 | 202,000.00 |